Triazole compounds that modulate HSP90 activity
US8188075B2 · kind B2 · utility
26Cited by
0References
46Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 14, 2007 |
| Grant date | May 29, 2012 |
| Priority date | — |
| Expiry date | Sep 25, 2028 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to substituted triazole compounds and compositions comprising substituted triazole compounds. The invention further relates to methods of treating or inhibiting angiogenesis in a subject in need thereof and methods for blocking, occluding, or otherwise disrupting blood flow in neo vasculature, in a subject in need thereof comprising administering to the subject a substituted triazole compound of the invention, or a composition comprising such a compound.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.